Night Helper Blog LLC on MSN6 天
MaxBoost Plus: We Tested It—Here's Our Honest MaxBoost Plus Review After 111 Days!
In today's demanding world, achieving optimal health and maintaining peak performance is more crucial than ever. Many ...
Monthly Prescribing Reference15 天
FDA Drug Approval Decisions Expected in December 2024
If approved, sotagliflozin would be the first oral medication for patients with T1D. The FDA is reviewing the BLA for datopotamab deruxtecan (Dato-DXd), a specifically engineered TROP2-directed ...
Nature20 天
FDA approves PI3Kα inhibitor that does double duty as a degrader
The FDA has approved Genentech’s inavolisib (Itovebi) in combination with the CDK4/6 inhibitor palbociclib and the oestrogen-receptor antagonist fulvestrant for endocrine-resistant, PIK3CA ...
News2420 天
Fighting chance: Umhlanga cancer patient's bid for unregistered medication finally approved
South Africans need to be in the know if we want to create a prosperous future. News24 has kept the country informed for 25 years, and we're about to enter a new chapter of fearless journalism. Join ...
The Hill20 天
IV fluid maker says expiration date extensions approved
The Food and Drug Administration approved changing the expiration date on multiple types of intravenous and sterile fluids made by Baxter International earlier this week, the company said in a ...
FiercePharma21 天
Protega scores FDA nod for new dosage of abuse-deterrent opioid Roxybond
The FDA has approved the first abuse-deterrent, immediate-release, 10 mg opioid tablet for pain management, signing off on another dosage of Protega Pharmaceuticals’ Roxybond. The nod covers ...
Targeted Oncology21 天
FDA Expands Approval for Jylamvo Oral Methotrexate Solution in ALL
The FDA has expanded the approval for Jylamvo, an oral methotrexate solution, to include pediatric patients with acute lymphoblastic leukemia (ALL). Jylamvo was the first oral methotrexate solution ...
The Conversation21 天
Alzheimer’s drug approved in the UK, but it won’t be available on the NHS – here’s why
Rahul Sidhu does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...
Seeking Alpha21 天
Iterum Therapeutics plc (ITRM) U.S. FDA Approval of ORLYNVAH Call (Transcript)
Please go ahead. Thank you, Lydia. Good morning, and thank you for joining today's call to discuss the recent FDA approval of ORLYNVAH. A press release with details of the approval was issued on ...
Yahoo Finance22 天
FDA approves Iterum’s ORLYNVAH NDA for uUTI treatment
The US Food and Drug Administration (FDA) has approved Iterum Therapeutics' new drug application (NDA) for ORLYNVAH (sulopenem etzadroxil and probenecid) to treat uncomplicated urinary tract ...
Pharmaceutical Technology22 天
FDA approves Iterum’s ORLYNVAH NDA for uUTI treatment
ORLYNVAH is indicated for the treatment of uUTIs in adult women. Credit: 9nong/Shutterstock. The US Food and Drug Administration (FDA) has approved Iterum Therapeutics‘ new drug application (NDA) for ...
BioSpace22 天
Iterum Wins FDA Approval For Oral UTI Antibiotic, Seeks ‘Strategic Transaction’ for Asset
Orlynvah is the first oral penem approved in the U.S. and Iterum Therapeutics’ first FDA-approved product. CEO Corey Fishman said the company will renew its efforts to look for a potential partner to ...